IL165486A0 - Method composition and kit for antigenic binding of norwalk-like viruses - Google Patents

Method composition and kit for antigenic binding of norwalk-like viruses

Info

Publication number
IL165486A0
IL165486A0 IL16548603A IL16548603A IL165486A0 IL 165486 A0 IL165486 A0 IL 165486A0 IL 16548603 A IL16548603 A IL 16548603A IL 16548603 A IL16548603 A IL 16548603A IL 165486 A0 IL165486 A0 IL 165486A0
Authority
IL
Israel
Prior art keywords
nlv
host
norwalk
viruses
kit
Prior art date
Application number
IL16548603A
Other languages
English (en)
Original Assignee
Pendu Le Jacques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pendu Le Jacques filed Critical Pendu Le Jacques
Publication of IL165486A0 publication Critical patent/IL165486A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL16548603A 2002-05-31 2003-06-02 Method composition and kit for antigenic binding of norwalk-like viruses IL165486A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38528302P 2002-05-31 2002-05-31
US38529602P 2002-05-31 2002-05-31
PCT/US2003/017247 WO2003101176A2 (fr) 2002-05-31 2003-06-02 Procede, composition et kit de liaison antigene de virus de norwalk

Publications (1)

Publication Number Publication Date
IL165486A0 true IL165486A0 (en) 2006-01-15

Family

ID=29715363

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16548603A IL165486A0 (en) 2002-05-31 2003-06-02 Method composition and kit for antigenic binding of norwalk-like viruses

Country Status (9)

Country Link
US (3) US20060057562A1 (fr)
EP (1) EP1532279B1 (fr)
AT (1) ATE498403T1 (fr)
AU (2) AU2003273206B2 (fr)
CA (1) CA2487846C (fr)
DE (1) DE60336063D1 (fr)
DK (1) DK1532279T3 (fr)
IL (1) IL165486A0 (fr)
WO (1) WO2003101176A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572862B1 (en) * 1989-11-08 2003-06-03 Baylor College Of Medicine Methods and reagents to detect and characterize Norwalk and related viruses
WO2003101176A2 (fr) * 2002-05-31 2003-12-11 Children's Hospital Medical Center Procede, composition et kit de liaison antigene de virus de norwalk
RU2300826C2 (ru) * 2005-08-05 2007-06-10 Василий Иванович Швейкин Инжекционный излучатель
US8486421B2 (en) 2009-06-09 2013-07-16 Children's Hospital Medical Center Antigen-norovirus P-domain monomers and dimers, antigen-norovirus P-particle molecules, and methods for their making and use
US9321803B2 (en) 2013-07-12 2016-04-26 Children's Hospital Medical Center Compositions and methods for inhibiting norovirus infection
EP3600397A4 (fr) 2017-03-28 2021-01-27 Children's Hospital Medical Center Vaccins à base de particules s de norovirus et leurs procédés de fabrication et d'utilisation
CN115343485B (zh) * 2022-10-18 2023-01-06 天津德祥生物技术股份有限公司 血型抗原三糖偶联物在血型抗体检测中的应用
EP4382914B1 (fr) * 2022-10-18 2025-06-11 Tianjin Dexiang Biotechnology Co., Ltd. Utilisation d'un conjugué trisaccharide d'antigène de groupe sanguin dans la détection d'anticorps de groupe sanguin

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916213A (en) * 1983-02-22 1990-04-10 Xoma Corporation Ribosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereof
US5643579A (en) * 1984-11-01 1997-07-01 American Home Products Corporation Oral vaccines
US5338689A (en) 1987-08-24 1994-08-16 Stiftung Fur Diagnostische Forschung Method and card for detecting antigens and/or antibodies
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US5068191A (en) * 1989-08-31 1991-11-26 The Biomembrane Institute Purified histo-blood group a glycosyltransferase and antibodies thereto
JP3310281B2 (ja) * 1989-11-08 2002-08-05 ベイラー カレッジ オブ メディシン ノーワーク及び関連のウィルスを検出し同定するための方法と試薬
CA2029219A1 (fr) * 1989-11-08 1991-05-09 Mary K. Estes Methodes et reactifs permettant de deceler et de caracteriser le virus de norwalk et les virus connexes
FR2677767B1 (fr) * 1991-06-11 1994-10-14 Biotechnologie Ste Europeenne Procede de detection de l'infection par le virus de la diarrhee bovine, sequence nucleotidique codant pour une proteine induite par l'infection par ce virus et proteines et antigenes recombinants s'y rapportant .
DK0590060T3 (da) * 1991-06-21 1998-05-11 Univ Cincinnati Oralt indgivelige terapeutiske proteiner samt fremgangsmåde til fremstilling
US5254342A (en) * 1991-09-30 1993-10-19 University Of Southern California Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
WO1993019660A1 (fr) * 1992-04-03 1993-10-14 Baylor College Of Medicine Therapie genique utilisant l'intestin
US5374532A (en) * 1992-08-31 1994-12-20 The Biomembrane Institute Method for determining susceptibility to escherichia coli urinary tract infections and method for diagnosing secretors and nonsecretors
DE4335025A1 (de) * 1993-10-14 1995-04-20 Boehringer Ingelheim Int Endosomolytisch wirksame Partikel
US5750394A (en) * 1994-05-20 1998-05-12 The Mount Sinai Medical Center Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
US6300090B1 (en) * 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
US5861241A (en) * 1995-08-16 1999-01-19 University Of Massachusetts Monoclonal antibodies for detecting Norwalk virus
EP0845995A1 (fr) * 1995-08-18 1998-06-10 Dr. Rentschler Biotechnologie GmbH Compositions pharmaceutiques servant a l'inhibition competitive de la fixation d'un retrovirus sur le recepteur ifn et procede de diagnostic d'une infection a vih
KR970016372U (ko) * 1995-10-04 1997-05-23 음식물 쓰레기 처리장치
US5891862A (en) * 1996-03-15 1999-04-06 Geltex Pharmaceuticals, Inc. Polyvalent polymers for the treatment of rotavirus infection
IL118625A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibodies
US6225290B1 (en) * 1996-09-19 2001-05-01 The Regents Of The University Of California Systemic gene therapy by intestinal cell transformation
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US20020019991A1 (en) * 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
JP2004534088A (ja) * 2001-07-06 2004-11-11 スローン−ケッタリング・インスティテュート・フォア・キャンサー・リサーチ 癌のための多価コンジュゲートワクチン
WO2003101176A2 (fr) * 2002-05-31 2003-12-11 Children's Hospital Medical Center Procede, composition et kit de liaison antigene de virus de norwalk
US7443123B2 (en) * 2004-10-21 2008-10-28 Shop Vac Corporation Method and apparatus for preventing overheating in an electronically commutated motor assembly

Also Published As

Publication number Publication date
AU2009238339A1 (en) 2009-12-10
CA2487846A1 (fr) 2003-12-11
EP1532279A4 (fr) 2005-11-09
AU2003273206A1 (en) 2003-12-19
DK1532279T3 (da) 2011-05-23
AU2009238339B2 (en) 2011-06-30
EP1532279B1 (fr) 2011-02-16
EP1532279A2 (fr) 2005-05-25
ATE498403T1 (de) 2011-03-15
US20060057562A1 (en) 2006-03-16
AU2003273206B2 (en) 2009-08-20
US20120071436A1 (en) 2012-03-22
WO2003101176A8 (fr) 2005-11-10
DE60336063D1 (de) 2011-03-31
WO2003101176A2 (fr) 2003-12-11
US20080274984A1 (en) 2008-11-06
WO2003101176A3 (fr) 2005-03-24
US8026221B2 (en) 2011-09-27
CA2487846C (fr) 2012-05-29

Similar Documents

Publication Publication Date Title
SG170119A1 (en) Nutritional composition comprising indigestible oligosaccharides
WO2002000242A8 (fr) Traitement des infections par le papillomavirus
WO2009060281A3 (fr) Analogues d'oligoribonucléotides immunostimulants contenant des fractions oligophosphates modifiées
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
NO20031646D0 (no) Ajuvantsammensetning omfattende et immunostimulatorisk oligonukleotid og entokol
WO2004016750A3 (fr) Anticorps specifiques du recepteur fc$g(g)riib et procedes d'utilisation de ces anticorps
NZ617196A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
WO2006065553A3 (fr) Vaccins glycoconjugues contenant un peptidoglycane
DE60121545D1 (de) Virus des porzinen reproduktiven und respiratorischen syndroms und dessen verwendung
EP2027874A3 (fr) Procédés d'administration/dosage d'anticorps anti-rsv pour la prophylaxie et le traitement
WO2003059385A3 (fr) Vaccin contre le vih et procede d'utilisation
IL165486A0 (en) Method composition and kit for antigenic binding of norwalk-like viruses
WO2008150275A3 (fr) Procédés pour empêcher et améliorer la maladie associée au virus du syndrome dysgénésique respiratoire du porc par immunisation contre l'infection du ttv porcin
WO2004110392A3 (fr) Compositions et methodes de traitement d'une infection a coronavirus et du sras
EP1305042A4 (fr) Compositions et procedes de traitement des infections muqueuses
WO2003083083A3 (fr) Procedes d'utilisation d'un ligand flt3 dans des protocoles d'immunisation
SE0401631L (sv) Ny sammansättning
EA200100515A2 (ru) Диазепиноиндолы для лечения хронического обструктивного заболевания легких
EP2364726A3 (fr) Vaccin contre l'infection Neisseria
BRPI0414073A (pt) método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo
EP1905449A3 (fr) Composition adjuvante continant une saponine et un oligonucleotide immunostimulateur
SG159525A1 (en) Vaccine
WO2002024887A3 (fr) Echangeurs a specificite de ligands/recepteurs permettant le reacheminement d'anticorps vers des recepteurs sur un agent pathogene